237 related articles for article (PubMed ID: 33126893)
1. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire.
Capota R; Militaru S; Ionescu AA; Rosca M; Baicus C; Popescu BA; Jurcut R
Health Qual Life Outcomes; 2020 Oct; 18(1):351. PubMed ID: 33126893
[TBL] [Abstract][Full Text] [Related]
2. Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy.
Huff CM; Turer AT; Wang A
Qual Life Res; 2013 Apr; 22(3):647-52. PubMed ID: 22544415
[TBL] [Abstract][Full Text] [Related]
3. Comparison Between the Kansas City Cardiomyopathy Questionnaire and New York Heart Association in Assessing Functional Capacity and Clinical Outcomes.
Hawwa N; Vest AR; Kumar R; Lahoud R; Young JB; Wu Y; Gorodeski EZ; Cho L
J Card Fail; 2017 Apr; 23(4):280-285. PubMed ID: 27940335
[TBL] [Abstract][Full Text] [Related]
4. Validation of heart failure quality of life tool and usage to predict all-cause mortality in acute heart failure in Uganda: the Mbarara heart failure registry (MAHFER).
Okello S; Abeya FC; Lumori BAE; Akello SJ; Moore CC; Annex BH; Buda AJ
BMC Cardiovasc Disord; 2018 Dec; 18(1):232. PubMed ID: 30541443
[TBL] [Abstract][Full Text] [Related]
5. New York Heart Association Class and Kansas City Cardiomyopathy Questionnaire in Acute Heart Failure.
Huo X; Pu B; Wang W; Peng Y; Li J; Lei L; Zhang L; Li J
JAMA Netw Open; 2023 Oct; 6(10):e2339458. PubMed ID: 37874564
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure.
Watanabe-Fujinuma E; Origasa H; Bamber L; Roessig L; Toyoda T; Haga Y; Gwaltney C; Pieske B
Health Qual Life Outcomes; 2020 Jul; 18(1):236. PubMed ID: 32680513
[TBL] [Abstract][Full Text] [Related]
7. Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.
Napier R; McNulty SE; Eton DT; Redfield MM; AbouEzzeddine O; Dunlay SM
JACC Heart Fail; 2018 Jul; 6(7):552-560. PubMed ID: 29885952
[TBL] [Abstract][Full Text] [Related]
8. Testosterone and quality of life in patients with dilated cardiomyopathy.
Diaconu R; Neagoe O; Mirea O; Tieranu E; Mustafa R; Balseanu TA; Donoiu I
Discoveries (Craiova); 2022; 10(3):e156. PubMed ID: 36540088
[TBL] [Abstract][Full Text] [Related]
9. Adapting and usability testing of the Kansas city cardiomyopathy questionnaire (KCCQ) in a heart failure clinic in Tanzania: the Swahili KCCQ.
Chillo P; Mlay J; Akanyirige PW; Majani N; Janabi M; Kaaya S; Hawkins C; Hirschhorn LR
BMC Cardiovasc Disord; 2023 May; 23(1):242. PubMed ID: 37149565
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Nassif M; Fine JT; Dolan C; Reaney M; Addepalli P; Allen VD; Sehnert AJ; Gosch K; Spertus JA
JACC Heart Fail; 2022 Aug; 10(8):531-539. PubMed ID: 35902155
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study.
Stehlik J; Mountis M; Haas D; Palardy M; Ambardekar AV; Estep JD; Ewald G; Russell SD; Robinson S; Jorde U; Taddei-Peters WC; Jeffries N; Richards B; Khalatbari S; Spino C; Baldwin JT; Mann D; Stewart GC; Aaronson KD;
J Heart Lung Transplant; 2020 Jan; 39(1):27-36. PubMed ID: 31822442
[TBL] [Abstract][Full Text] [Related]
12. Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study.
Tower-Rader A; Szpakowski N; Popovic ZB; Bittel B; Fava A; Ospina S; Xu B; Thamilarasan M; Mentias A; Smedira NG; Desai MY
Prog Cardiovasc Dis; 2023; 80():66-73. PubMed ID: 37302651
[TBL] [Abstract][Full Text] [Related]
13. Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach.
Gallagher AM; Lucas R; Cowie MR
ESC Heart Fail; 2019 Feb; 6(1):3-9. PubMed ID: 30311454
[TBL] [Abstract][Full Text] [Related]
14. Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry.
Teramoto K; Tay WT; Tromp J; Katherine Teng TH; Chandramouli C; Ouwerkerk W; Lawson CA; Huang W; Hung CL; Chopra V; Anand I; Mark Richards A; Lam CSP
Circ Cardiovasc Qual Outcomes; 2023 Jan; 16(1):e009134. PubMed ID: 36484254
[TBL] [Abstract][Full Text] [Related]
15. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP
J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813
[TBL] [Abstract][Full Text] [Related]
16. Change of Health-Related Quality of Life Over Time and Its Association With Patient Outcomes in Patients With Heart Failure.
Sepehrvand N; Savu A; Spertus JA; Dyck JRB; Anderson T; Howlett J; Paterson I; Oudit GY; Kaul P; McAlister FA; Ezekowitz JA;
J Am Heart Assoc; 2020 Sep; 9(17):e017278. PubMed ID: 32812460
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the portuguese version of the Kansas City cardiomyopathy questionnaire in dilated cardiomyopathy with congestive heart failure.
Nave-Leal E; Pais-Ribeiro J; Oliveira MM; Da Silva N; Soares R; Fragata J; Ferreira R
Rev Port Cardiol; 2010 Mar; 29(3):353-72. PubMed ID: 20635562
[TBL] [Abstract][Full Text] [Related]
18. Reliability and Validity of Kansas City Cardiomyopathy Questionnaire in Arabic Patients with Chronic Heart Failure.
Albarrati AM; Altimani R; Almogbel O; Alnahdi AH; Almurdi MM; Abuammah A; Nazer R
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003959
[No Abstract] [Full Text] [Related]
19. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Spertus JA; Fine JT; Elliott P; Ho CY; Olivotto I; Saberi S; Li W; Dolan C; Reaney M; Sehnert AJ; Jacoby D
Lancet; 2021 Jun; 397(10293):2467-2475. PubMed ID: 34004177
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure.
Hejjaji V; Tang Y; Coles T; Jones PG; Reeve BB; Mentz RJ; Spatz ES; Dunlay SM; Caldwell B; Saha A; Tarver ME; Tran A; Patel KK; Henke D; Piña IL; Spertus JA
Circ Heart Fail; 2021 Sep; 14(9):e008284. PubMed ID: 34465123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
